Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiovascular Disease Risk and Noncardiovascular Chronic Disease Burden by Housing Status.

Journal of the American Heart Association·2026
Same author

Performance of PREVENT Cardiovascular Risk in Electronic Health Record-Based Clinical Practice.

JAMA network open·2026
Same author

Lifetime Adverse Pregnancy Outcome History and Cardiovascular Risk.

Hypertension (Dallas, Tex. : 1979)·2026
Same author

Criteria to Assess the Predictive and Clinical Utility of Novel Models, Biomarkers, and Tools for Risk of Cardiovascular Disease: A Scientific Statement From the American Heart Association.

Circulation·2026
Same author

A federated learning framework for ethical dynamic treatment allocation across heterogeneous hospitals.

Journal of biomedical informatics·2026
Same author

FairPOT: Balancing AUC Performance and Fairness with Proportional Optimal Transport.

Proceedings of the AAAI/ACM Conference on AI, Ethics, and Society·2025

Related Experiment Video

Updated: Jul 14, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Lifetime risk for developing dyslipidemia: the Framingham Offspring Study.

Mark R Cobain1, Michael J Pencina, Ralph B D'Agostino

  • 1Department of Mathematics/Statistics and Biostatistics, Boston University, Boston, Mass, USA.

The American Journal of Medicine
|July 3, 2007
PubMed
Summary

The lifetime risk of developing dyslipidemia is substantial, with most individuals developing high LDL or low HDL cholesterol over time. These risks significantly exceed previous prevalence estimates.

Related Experiment Videos

Last Updated: Jul 14, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Area of Science:

  • Cardiovascular Health
  • Lipid Metabolism
  • Preventive Medicine

Background:

  • High serum low-density lipoprotein (LDL) cholesterol and low high-density lipoprotein (HDL) cholesterol are significant vascular risk factors.
  • National surveys show high prevalence of borderline-high LDL (40%) and low HDL (13-34%) in the US.
  • The lifetime risk of developing dyslipidemia remains largely unknown.

Purpose of the Study:

  • To estimate the 10- to 30-year long-term risks of developing borderline-high LDL, high LDL, and low HDL cholesterol.
  • To analyze these risks across different age groups and sexes.
  • To assess risks considering baseline dyslipidemia prevalence.

Main Methods:

  • Analysis of 4701 Framingham Offspring Study participants with at least two examinations between 1971 and 2000.
  • Sex-specific risk estimations for age groups 30-54 years.
  • Calculation of risks conditional on survival without dyslipidemia and accounting for baseline prevalence.

Main Results:

  • Over 30 years, 60% developed borderline-high LDL, 40% developed high LDL, and 20-40% developed low HDL.
  • Adjusted 30-year risks reached 80% for borderline-high LDL, 50% for high LDL, and 25-65% for low HDL.
  • 20-50% had or developed both low HDL and high LDL; 30-year risks approximate lifetime risk for 50-year-olds.

Conclusions:

  • Long-term risks for developing dyslipidemia are substantial in both men and women.
  • These risks considerably surpass prevalence estimates derived from cross-sectional surveys.
  • Individuals face a high likelihood of developing abnormal lipid profiles over their lifespan.